✦ LIBER ✦

Combination immunotherapy with prostate GVAX and ipilimumab: safety and toxicity

✍ Scribed by Karan, Dev; Van Veldhuizen, Peter

Book ID: 120643412
Publisher: Future Medicine
Year: 2012
Tongue: English
Weight: 445 KB
Volume: 4
Category: Article
ISSN: 1750-743X
DOI: 10.2217/imt.12.53

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined immunotherapy with granulocyte-

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Alfons JM van den Eertwegh; Jurjen Versluis; H Pieter van den Berg; Saskia JAM S 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 306 KB

188Re-HEDP combined with capecitabine in

188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study

✍ Marnix G. E. H. Lam; Tjitske B. Bosma; Peter P. van Rijk; Bernard A. Zonnenberg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 229 KB

Combined Image Guided IMRT and Prostate

Combined Image Guided IMRT and Prostate Seed Brachytherapy in Patients with Organ-confined Prostate Cancer: Acute and Late Toxicity

✍ R. Fuhrer; R.J. Miller; A. Kirichenko; V. Valakh; T. Sunder 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

222. Results and toxicity of immunothera

222. Results and toxicity of immunotherapy with genetically modified tumor vaccine (GMTV) combined with brain metastases irradiation in melanoma patients

✍ A. Karczewska-Dzionk; S. Nawrocki; P. Wysocki; P. Milecki; D.W. Kowalczyk; G. St 📂 Article 📅 2003 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 108 KB

Tolerability, safety and pharmacokinetic

Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)

✍ Meulenbeld, Hielke J.; Bono, Johann S.; Tagawa, Scott T.; Whang, Young E.; Li, X 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 449 KB

New directions with hormone therapy in p

New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy

✍ R.T.D. Oliver 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 218 KB